Table 4.

Cancer diagnosis, stage, and treatment according to reduced appetite (mean VAS ≤ 70 mm) and reduced dietary intake (mean FIVS < 75%) across the three assessment days (n = 77)

	Appetite (VAS ≤ 70 mm)	p-value*	Dietary intake (FIVS < 75%)	p-value*
Cancer diagnosis
Gastrointestinal	27 (50%) −2.7		25 (46.3%)−2.6
Lung	15 (78.9%)2.0	0.021	15 (78.9%)2.3	0.035
Head and Neck	4 (100%)1.7		3 (75%)0.8
Cancer staging
I	1 (33.3%)		1 (33.3%)
II	5 (71.4%)	0.701	6 (85.7%)	0.364
III	17 (65.4%)		14 (53.8%)
IV	18 (62.1%)		16 (55.2%)
Cancer treatment (< 3 months)
Surgery
No	40 (60.6%)	0.704	37 (56.1%)	0.925
Yes	6 (54.5%)		6 (54.5%)
Chemotherapy
No	25 (53.2%)	0.142	22 (46.8%)	0.046
Yes	21 (70.0%)		21 (70.0%)
Radiotherapy
No	39 (56.5%)	0.091	36 (52.2%)	0.057
Yes	7 (87.5%)		7 (87.5%)

^*Chi-square test

Superscript values represent adjusted residuals from the chi-square test. Absolute values ≥ 1.96 indicate a statistically significant contribution to the association

(p < 0.05). Positive residuals indicate observed frequencies higher than expected, whereas negative residuals indicate observed frequencies lower than expected